General MedicationsORALStandard
POSACONAZOLE
POSACONAZOLE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview POSACONAZOLE is listed in Drugs@FDA under application 218434 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient POSACONAZOLE Form and strength TABLET, DELAYED RELEASE;ORAL - 100MG Sponsor MSN Submission history Latest submission status date: 2025-10-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview POSACONAZOLE is listed in Drugs@FDA under application 218434 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient POSACONAZOLE Form and strength TABLET, DELAYED RELEASE;ORAL - 100MG Sponsor MSN Submission history Latest submission status date: 2025-10-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.